Artificial Intelligence in Dialysis Care - presented by Dr. Peter Kotanko MD, FASN and Dr Damien Ashby

Artificial Intelligence in Dialysis Care

Dr. Peter Kotanko MD, FASN

Dr. Peter Kotanko MD, FASN
Gold SponsorSilver SponsorBronze Sponsor
Sponsor logo
Sponsor logo
Sponsor logo
Artificial Intelligence in Dialysis Care
Dr. Peter Kotanko MD, FASN
Peter Kotanko
Renal Research Institute
Chaired by Damien Ashby

Today, in our everyday lives, artificial intelligence (AI) applications are omnipresent, from voice recognition to route planning, fraud protection, and on-line shopping recommendations. The pervasiveness of AI in our personal lives begets the question “What is the role of AI in dialysis care?”.

In dialysis care, three main application areas for “classical” AI (i.e., non-generative AI) have emerged [1]: prediction, therapy recommendation, and diagnosis. Examples are the prediction of hospital admissions and prediction of intradialytic hypotension in real-time. The former was implemented already in clinical practice and resulted in a lower hospitalization rate [2]. The latter involves the cloud-based integration of dialysis machine data, and electronic health records with AI-powered prediction algorithms [3]. In several countries AI applications are used to give anemia therapy recommendations [4] that are subsequently reviewed by health care providers prior to prescription. The application of such an AI tool has resulted in improved attainment of target hemoglobin targets, less severe anaemia, and lower ESA utilization [5]. Regarding diagnostics, AI systems have been developed to categorize arterio-venous aneurysms as advanced / non-advanced [6]. In addition, natural language processing, an AI method to extract insights from health care provider notes, has been shown to be superior to billing codes to identify symptom burden in hemodialysis patients [7].

The recent advent of generative AI and large language models (LLM) such as ChatGPT has instigated research into applications in dialysis care. For example, LLMs are explored to support renal dietitians and provide better personalized care. So far, results have shown only moderate performance of LLMs [8].

It is expected that AI applications, both “classical” and “generative”, will be expanded in the future. Moving forward, it will be critically important to recognize potential flaws of AI systems, such as biases and it “black box” character, and to respect ethical and privacy concerns.

References
  • 1.
    P. Kotanko et al. (2023) Artificial Intelligence and Machine Learning in Dialysis. CJASN
  • 2.
    S. Chaudhuri et al. (2021) Machine learning directed interventions associate with decreased hospitalization rates in hemodialysis patients. International Journal of Medical Informatics
  • 3.
    H. Zhang et al. (2023) Real-time prediction of intradialytic hypotension using machine learning and cloud computing infrastructure. Nephrology Dialysis Transplantation
  • 4.
    C. Barbieri et al. (2016) An international observational study suggests that artificial intelligence for clinical decision support optimizes anemia management in hemodialysis patients. Kidney International
  • 5.
    https://pubmed.ncbi.nlm.nih.gov/38382484
  • 6.
    H. Zhang et al. (2021) Deep learning to classify arteriovenous access aneurysms in hemodialysis patients. Clinical Kidney Journal
  • 7.
    L. Chan et al. (2019) Natural language processing of electronic health records is superior to billing codes to identify symptom burden in hemodialysis patients. Kidney International
  • 8.
    Wang L, et al. Application of Large Language Models such as ChatGPT to Support Nutritional Recommendations for Dialysis Patients [abstract]. J Am Soc Nephrol. 2023;34:91
Imperial College Renal and Transplant Centre logo
Dialysis Academy 2024
Imperial College Renal and Transplant Centre
Cite as
P. Kotanko (2024, March 15), Artificial Intelligence in Dialysis Care
Share
Details
Listed event This event is open to all
Recorded Available to all
Video length 1:05:22
Q&A Now closed